Saving and Improving Lives by Addressing Cancer-Associated Thrombosis

Cancer-associated thrombosis (blood clots) is a leading cause of death in cancer patients. It affects patients of all cancer types, at all cancer stages. It is essential that the Europe’s Beating Cancer Plan and the EU Cancer Mission both improve our understanding of this common comorbidity and its effect on cancer outcomes in Europe, and apply existing patient safety tools to advance cancer diagnosis, care and outcomes.

The ETHA calls upon the European Commission, the Cancer Mission Board and Assembly, and all other relevant stakeholders to decrease cancer mortality by addressing cancer-associated thrombosis. Cancer is a strong risk factor for developing thrombosis and thrombosis is an important early warning sign for cancer; cancer patients have a four-times higher risk than the general population of developing thrombosis. As such, it is vital that it is addressed both within the Europe’s Beating Cancer Plan (EBCP) and the EU Cancer Mission.

Click here to read the full brochure: Saving and Improving Lives by Addressing Cancer-Associated Thrombosis